Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Paine

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Digestive Diseases and Sciences|January 18, 2006
A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein contentAlan L Buchman, Mary F Paine, Anita Wallin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2023
A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and ChildrenSumit Bansal, Mayur K Ladumor, Mary F Paine, et al.
Clinical Pharmacology and Therapeutics|August 14, 2019
The Age of Omics-Driven Precision MedicineEliza R McColl, Rashi Asthana, Mary F Paine, et al.
Biopharmaceutics & Drug Disposition|December 30, 2016
Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juiceEmily J Johnson, Christina S Won, Kathleen Köck, et al.
Pharmaceutics|April 27, 2024
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?Kshitee Kharve, Andrew S Engley, Mary F Paine, et al.
Clinical and Translational Science|November 3, 2018
Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory AnalysisDan-Dan Tian, Senthil Natesan, John R White, et al.
Clinical and Translational Science|January 3, 2025
Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta-9-Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple RoutesLixuan Qian, Tao Zhang, Jean Dinh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 6, 1997
Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactionsR B Labroo, M F Paine, K E Thummel, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
6'7'-Dihydroxybergamottin contributes to the grapefruit juice effectShefali M Kakar, Mary F Paine, Paul W Stewart, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2013
A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitorsScott J Brantley, Tyler N Graf, Nicholas H Oberlies, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Digestive Diseases and Sciences|January 18, 2006
A higher dose requirement of tacrolimus in active Crohn's disease may be related to a high intestinal P-glycoprotein contentAlan L Buchman, Mary F Paine, Anita Wallin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2023
A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and ChildrenSumit Bansal, Mayur K Ladumor, Mary F Paine, et al.
Clinical Pharmacology and Therapeutics|August 14, 2019
The Age of Omics-Driven Precision MedicineEliza R McColl, Rashi Asthana, Mary F Paine, et al.
Biopharmaceutics & Drug Disposition|December 30, 2016
Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juiceEmily J Johnson, Christina S Won, Kathleen Köck, et al.
Pharmaceutics|April 27, 2024
Impact of Drug-Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought?Kshitee Kharve, Andrew S Engley, Mary F Paine, et al.
Clinical and Translational Science|November 3, 2018
Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory AnalysisDan-Dan Tian, Senthil Natesan, John R White, et al.
Clinical and Translational Science|January 3, 2025
Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta-9-Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple RoutesLixuan Qian, Tao Zhang, Jean Dinh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 6, 1997
Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactionsR B Labroo, M F Paine, K E Thummel, et al.
Clinical Pharmacology and Therapeutics|June 5, 2004
6'7'-Dihydroxybergamottin contributes to the grapefruit juice effectShefali M Kakar, Mary F Paine, Paul W Stewart, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 27, 2013
A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitorsScott J Brantley, Tyler N Graf, Nicholas H Oberlies, et al.
Pageof 18